Metropolis Healthcare (BOM:542650) YoY EBITDA Growth : 15.35% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Metropolis Healthcare YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Metropolis Healthcare's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 15.35%.

Metropolis Healthcare's EBITDA per Share for the three months ended in Mar. 2024 was ₹16.07.

Metropolis Healthcare YoY EBITDA Growth Historical Data

The historical data trend for Metropolis Healthcare's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metropolis Healthcare YoY EBITDA Growth Chart

Metropolis Healthcare Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

Get a 7-Day Free Trial

3.61

35.80

25.64

-19.29

-3.93

Metropolis Healthcare Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-11.04	-7.51	-8.81	-13.04	15.35

Metropolis Healthcare YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Metropolis Healthcare's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(56.756	-	59.076)	/	\| 59.076 \|
=	-3.93 %

Metropolis Healthcare's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(16.073	-	13.934)	/	\| 13.934 \|
=	15.35 %

Metropolis Healthcare YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Metropolis Healthcare's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Metropolis Healthcare (BOM:542650) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Metropolis Healthcare Ltd (BOM:542650) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

METROPOLIS:India

Address

Hind Cycle Marg, 250-D, Udyog Bhavan, Behind Glaxo, Worli, Mumbai, MH, IND, 400 030

Website

https://www.metropolisindia.com

Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.

Metropolis Healthcare (BOM:542650) Headlines

No Headlines